Specialty Ranbaxy - Breaking News - HCV 4 (Hep C Treatment)

Specialty Ranbaxy - Breaking News - HCV 4
LAUNCH OF HCV 4 FOR COMPLETE DIAGNOSIS OF HEPATITIS C INFECTION Diagnosis of Hepatitis C infection has always relied on the detection of Antibodies to the Hepatitis

BioCryst-Hepatitis C
population has been infected with HCV. According to the National Centers for Disease Control, as many as 75-85% of those infected with HCV will have chronic infection and 70% of

Chronic Hepatitis C: Current Disease Management
Testing for HCV RNA is also helpful in patients in whom EIA tests for anti-HCV are unreliable. For instance, immunocompromised patients may test negative for anti-HCV despite having HCV infection

HCV
HCV/Clinical: Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin Ferenci P et al J Hep 43 (2005) 425-433. HCV/Clinical: Pilot

Login
Please enter your account name and password. To register for an Account Name and Password please click here . Account Name: Password: Forgot your password? Change my password